Clinical Trial Update: Trial of Gemcitabine_Capecitabine Versus Gemcitabine_Carboplatin in Breast Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing gemcitabine-capecitabine versus gemcitabine-carboplatin in metastatic breast cancer; the current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Gemzar (gemcitabine)
• Xeloda (capecitabine)

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Metastatic Breast Cancer | Phase 3 | Status: UNKNOWN